TScan Therapeutics, Inc.(TCRX)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
TCRX is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.20.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.4%).
Did the stock rise after good news?
The next-day move after each of its last 7 EPS beats and 3 misses.
In plain words: it beat expectations 7 times, but the stock still fell 4 of those 7 times.
- Aug '26Missed▼ -0.5%
- May '26Missed▲ +3.3%
- Mar '26Beat▲ +4.3%
- Nov '25Beat▼ -2.5%
- Aug '25Beat▲ +3.7%
- May '25Beat▼ -9.3%
- Mar '25Missed▼ -5.0%
- Nov '24Beat▼ -4.9%
- Mar '24Beat▲ +1.7%
- Nov '23Beat▼ -0.9%
Clear beats and misses with a known reaction only. What counts as a beat
Why did TCRX fall after beating earnings?
5 of TCRX's last 10 reactions went against the EPS result. What stands out in each:
TCRX beat EPS estimates in 7 quarters, and the stock still closed lower the next day 4 times. In 4 of the 4 where we have price data, the stock had already run up before the report.
- Nov 12, 2025EPS beat +15.2%stock -2.5% next day
- It had risen 8.9% in the final week before the report, so good news may already have been priced in.
- May 6, 2025EPS beat +7.1%stock -9.3% next day
- It had risen 36.4% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.0% lower as soon as trading resumed.
- Nov 12, 2024EPS beat +13.8%stock -4.9% next day
- It had risen 12.2% in the final week before the report, so good news may already have been priced in.
- Nov 9, 2023EPS beat +45.5%stock -0.9% next day
- It had risen 22.9% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 4.4% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 3)
- May 6, 2026EPS missed -37.5%stock +3.3% next day
- It had already fallen 4.0% in the final week before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was TCRX's earnings move already priced in?
TCRX's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does TCRX hold its opening gap after earnings?
TCRX's opening move after each report and where it closed that day.
In 7 reports TCRX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 7 times (71%), and fully reversed 4 times. Gaps up faded 1 of 2; gaps down recovered 4 of 5.
- Aug 12, 2026ReversedOpened +1.8%, closed -0.5%
- May 6, 2026ReversedOpened -1.7%, closed +3.3%
- Mar 4, 2026HeldOpened +1.4%, closed +4.3%
- May 6, 2025HeldOpened -2.0%, closed -9.3%
- Aug 12, 2024ReversedOpened -4.9%, closed +1.4%
- Mar 6, 2024ReversedOpened -3.3%, closed +1.7%
- Nov 9, 2023FadedOpened -4.4%, closed -0.9%
What the history says
- It fell after 4 of its 7 EPS beats (57%): beating estimates has not been enough on its own.
TCRX earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Before open | -$0.20 | -$0.23 | -15.0% | -0.51% | +0.26% |
| May 6, 2026 | Before open | -$0.16 | -$0.22 | -37.5% | +3.31% | +4.13% |
| Mar 4, 2026 | Before open | -$0.28 | -$0.18 | +35.7% | +4.35% | +8.21% |
| Nov 12, 2025 | Before open | -$0.33 | -$0.28 | +15.2% | -2.46% | -9.84% |
| Aug 12, 2025 | Before open | -$0.32 | -$0.28 | +12.5% | +3.73% | +12.42% |
| May 6, 2025 | Before open | -$0.28 | -$0.26 | +7.1% | -9.33% | -8.00% |
| Mar 5, 2025 | Before open | -$0.28 | -$0.29 | -3.6% | -4.95% | -1.98% |
| Nov 12, 2024 | Before open | -$0.29 | -$0.25 | +13.8% | -4.91% | -15.44% |
| Aug 12, 2024 | Before open | -$0.28 | -$0.28 | 0.0% | +1.35% | -4.90% |
| May 13, 2024 | Before open | -$0.24 | -$0.32 | -33.3% | — | — |
| Mar 6, 2024 | Before open | -$0.25 | -$0.11 | +56.0% | +1.71% | -6.83% |
| Nov 9, 2023 | Before open | -$0.44 | -$0.24 | +45.5% | -0.92% | +3.91% |
Consensus for the next report: EPS -$0.20, revenue $468,180.00.
TCRX Earnings FAQ
Answers computed from TScan Therapeutics, Inc.'s reported history
TCRX is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.20.
Over the last 12 quarters with a usable EPS surprise, TCRX beat the consensus estimate 7 times (58%), missed 4 and landed in line 1. It has missed estimates in each of the last 2 counted quarters.
Across its last 11 quarters with a measured reaction, TCRX moved an average of ±3.4% in the first session after reporting. It closed higher 46% of the time; the largest gain was 4.4% and the largest drop -9.3%.
TCRX fell in the first session after 4 of its last 7 EPS beats (57%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 4 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, TCRX moved an average of -0.1% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -1.3%. After a drop of 3% or more (5 quarters), it rose the next day 40% of the time, averaging -0.6%. This describes past reports; it is not a forecast.
In 7 reports TCRX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 7 times (71%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · TCRX: 12 reported quarters, latest Aug 12, 2026. Information only, not investment advice.
Looking for more on TCRX?
Price charts, forecast, fundamentals and risk pages for TCRX are not on Tickzen yet. You can run a full stock analysis now.
Run the TCRX Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun